EN | RU
EN | RU

Help Support

Back

SNT shows promising antidepressant effects in patients with treatment-resistant depression

Stanford neuromodulation therapy Stanford neuromodulation therapy
Stanford neuromodulation therapy Stanford neuromodulation therapy

What's new?

For treatment-resistant depression, Stanford neuromodulation therapy is superior to sham stimulation.

In a double-blind randomized controlled trial, Stanford neuromodulation therapy (SNT, an accelerated, high-dose, patterned, functional connectivity magnetic resonance imaging [fcMRI]-guided intermittent theta-burst stimulation [iTBS] protocol) substantially reduced depression symptoms following five days of intervention compared to an equivalent course of sham stimulation in a treatment-resistant sample. Eleanor J. Cole et al. sought to examine the antidepressant effectiveness of SNT for treatment-resistant depression.

Subjects having treatment-resistant depression who were undergoing moderate-to-severe depressive episodes were randomly allocated to get active or sham SNT. The area of the left dorsolateral prefrontal cortex that is most functionally anti-correlated with the subgenual anterior cingulate cortex was specifically targeted using resting-state functional MRI. Assessment of  the Montgomery- Åsberg Depression Rating Scale (MADRS) score four weeks following therapy was the major endpoint.

Overall, 32 subjects with treatment-resistant depression had been recruited at the time of the planned interim analysis, and 29 volunteers who continued to meet the requirements for inclusion got either active (n = 14) or sham (n = 15) SNT. In the active treatment group, the mean percent reduction in MADRS score from baseline at 4 weeks after treatment was greater when compared to the sham treatment group, as shown in Table 1:

SNT outperformed sham stimulation to relieve treatment-resistant depression. During the study, no severe adverse events took place. Due to SNT's short duration and high antidepressant efficacy, it offers a chance to treat patients in emergency or inpatient settings, where a compressed time course is required. To ascertain SNT's durability and to contrast it with alternative therapies, more trials should be conducted.

Source:

The American Journal of Psychiatry

Article:

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

Authors:

Eleanor J. Cole et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: